{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:26:10Z","timestamp":1783002370793,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001164","name":"Australian Synchrotron","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001164","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Protein Expression and Purification"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.pep.2016.01.004","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T02:15:23Z","timestamp":1452219323000},"page":"41-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Expression, purification and crystallization of human kynurenine aminotransferase 2 exploiting a highly optimized codon set"],"prefix":"10.1016","volume":"121","author":[{"given":"Guanchen","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Nematollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed A.","family":"Nadvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann H.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cy M.","family":"Jeffries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8033-5518","authenticated-orcid":false,"given":"W. Bret","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pep.2016.01.004_bib1","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.2174\/0929867322666150608094054","article-title":"Kynurenine aminotransferases and the prospects of inhibitors for the treatment of schizophrenia","volume":"22","author":"Jayawickrama","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pep.2016.01.004_bib2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.sbi.2008.09.009","article-title":"Curiosity to kill the KAT (kynurenine aminotransferase): structural insights into brain kynurenic acid synthesis","volume":"18","author":"Rossi","year":"2008","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.pep.2016.01.004_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1517\/14728220802665734","article-title":"New promises for manipulation of kynurenine pathway in cancer and neurological diseases","volume":"13","author":"Costantino","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.pep.2016.01.004_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuropharm.2014.03.004","article-title":"A\u00a0systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats","volume":"82","author":"Koshy Cherian","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pep.2016.01.004_bib5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S1461145708009383","article-title":"Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia","volume":"12","author":"Olsson","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pep.2016.01.004_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.semcdb.2015.03.002","article-title":"The kynurenine pathway and neurodegenerative disease","volume":"40","author":"Maddison","year":"2015","journal-title":"Semin. Cell & Dev. Biol."},{"key":"10.1016\/j.pep.2016.01.004_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.physbeh.2007.05.025","article-title":"The kynurenic acid hypothesis of schizophrenia","volume":"92","author":"Erhardt","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pep.2016.01.004_bib8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/schbul\/sbq151","article-title":"Exposure to kynurenic acid during adolescence produces memory deficits in adulthood","volume":"38","author":"Akagbosu","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pep.2016.01.004_bib9","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jpsychires.2013.08.008","article-title":"Activation of kynurenine pathway in ex\u00a0vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine","volume":"47","author":"Johansson","year":"2013","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.pep.2016.01.004_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.schres.2005.07.013","article-title":"Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia","volume":"80","author":"Nilsson","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pep.2016.01.004_bib11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0304-3940(01)02242-X","article-title":"Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia","volume":"313","author":"Erhardt","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pep.2016.01.004_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00018-009-0166-4","article-title":"Structure, expression, and function of kynurenine aminotransferases in human and rodent brains","volume":"67","author":"Han","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.pep.2016.01.004_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2091-11-19","article-title":"Thermal stability, pH dependence and inhibition of four murine kynurenine aminotransferases","volume":"11","author":"Han","year":"2010","journal-title":"BMC Biochem."},{"key":"10.1016\/j.pep.2016.01.004_bib14","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood\u2013Brain barrier transport of kynurenines: implications for brain synthesis and metabolism","volume":"56","author":"Fukui","year":"1991","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.pep.2016.01.004_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1471-4159.2007.04556.x","article-title":"Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain","volume":"102","author":"Guidetti","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.pep.2016.01.004_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.gene.2005.09.034","article-title":"Characterization of kynurenine aminotransferase III, a novel member of a phylogenetically conserved KAT family","volume":"365","author":"Yu","year":"2006","journal-title":"Gene"},{"key":"10.1016\/j.pep.2016.01.004_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1021\/ml300237v","article-title":"Structure-based design of irreversible human KAT II inhibitors: discovery of new potency-enhancing interactions","volume":"4","author":"Tuttle","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.pep.2016.01.004_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1021\/ml200204m","article-title":"Discovery of brain-penetrant, irreversible kynurenine aminotransferase II Inhibitors for Schizophrenia","volume":"3","author":"Dounay","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.pep.2016.01.004_bib19","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1093\/schbul\/sbt157","article-title":"Targeting kynurenine aminotransferase II in psychiatric diseases: promising effects of an orally active enzyme inhibitor","volume":"40","author":"Wu","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pep.2016.01.004_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuropharm.2015.10.028","article-title":"Inhibition of kynurenine aminotransferase II reduces activity of midbrain dopamine neurons","volume":"102","author":"Linderholm","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pep.2016.01.004_bib21","doi-asserted-by":"crossref","first-page":"W126","DOI":"10.1093\/nar\/gkm219","article-title":"OPTIMIZER: a web server for optimizing the codon usage of DNA sequences","volume":"35","author":"Puigb\u00f2","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pep.2016.01.004_bib22","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1074\/jbc.M707925200","article-title":"Crystal structure of human kynurenine aminotransferase II, a drug target for the treatment of schizophrenia","volume":"283","author":"Rossi","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pep.2016.01.004_bib23","series-title":"The Proteomics Protocols Handbook","first-page":"571","article-title":"Protein identification and analysis tools on the ExPASy server","author":"Gasteiger","year":"2005"},{"key":"10.1016\/j.pep.2016.01.004_bib24","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1074\/jbc.M708358200","article-title":"Crystal structure of human kynurenine aminotransferase II","volume":"283","author":"Han","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pep.2016.01.004_bib25","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/pro.408","article-title":"Gene optimization mechanisms: a multi-gene study reveals a high success rate of full-length human proteins expressed in Escherichia coli","volume":"19","author":"Maertens","year":"2010","journal-title":"Protein Sci."},{"key":"10.1016\/j.pep.2016.01.004_bib26","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tibtech.2004.04.006","article-title":"Codon bias and heterologous protein expression","volume":"22","author":"Gustafsson","year":"2004","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.pep.2016.01.004_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1047-8477(03)00044-3","article-title":"Protein production in Escherichia coli for structural studies by X-ray crystallography","volume":"142","author":"Goulding","year":"2003","journal-title":"J.\u00a0Struct. Biol."}],"container-title":["Protein Expression and Purification"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592816300043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592816300043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T04:56:55Z","timestamp":1537073815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046592816300043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":27,"alternative-id":["S1046592816300043"],"URL":"https:\/\/doi.org\/10.1016\/j.pep.2016.01.004","relation":{},"ISSN":["1046-5928"],"issn-type":[{"value":"1046-5928","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression, purification and crystallization of human kynurenine aminotransferase 2 exploiting a highly optimized codon set","name":"articletitle","label":"Article Title"},{"value":"Protein Expression and Purification","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pep.2016.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}